Li Shiyuan, Zhang Shengliang
Department of Gastrointestinal and Breast Surgery, Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou Province, China.
Department of Gastrointestinal and Breast Surgery, Guizhou University of Traditional Chinese Medicine, The First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine of China, Guiyang, Guizhou Province, China.
Medicine (Baltimore). 2025 Aug 15;104(33):e43387. doi: 10.1097/MD.0000000000043387.
According to Chinese medicine, surgical trauma and chemotherapy aggravate patients' qi and blood deficiency and damage to the veins and channels. The combination of Chinese medicine and neoadjuvant chemotherapy (NACT) can not only improve the above symptoms, but also is expected to alleviate the adverse effects of breast cancer chemotherapy, such as nausea and vomiting, thereby improving patient compliance to achieve tumor reduction or even tumor-free, and providing a new diagnostic and therapeutic idea for the clinical treatment of breast cancer. This paper reported a case of human epidermal growth factor receptor 2 (HER-2) invasive breast cancer treated with traditional Chinese medicine combined with NACT. The lesion disappeared after 2 months of treatment and effectively reduced nausea and the symptoms of loss of appetite during NACT.
The patient was a female, 54-year-old, unintentionally found a double breast lump with tingling pain over 1 year. During this period, the patient did not pay attention to any treatment, the mass increased progressively, hard texture, unclear boundary. Denied family genetic history of breast cancer. The patient was diagnosed with invasive ductal carcinoma of both breasts (multiple metastases in right axillary and supraclavicular lymph nodes), T4N3M0 (tumour staging basis), stage IIC, HER-2 positive by breast needle biopsy. In the course of NACT, the patient complained of severe nausea and vomiting, which seriously affected the quality of life and chemotherapy confidence.
The patient was diagnosed with invasive ductal carcinoma of both breasts (multiple metastases in right axillary and supraclavicular lymph nodes), T4N3M0, stage IIC, HER-2 positive.
The patient was treated with NACT, and traditional Chinese medicine was taken orally.
After 2 months of combination therapy, the breast mass shrank, the symptoms of nausea and vomiting were significantly relieved, and the appetite became better. The biopsy of the breast tissue cut at the completion of NACT showed no upper, lower, internal, outer, and basal lesions.
Chinese medicine internal effect is remarkable and safe, new adjuvant chemotherapy combined with Chinese medicine internal effectively improve nausea, vomiting symptoms, and effectively inhibit tumor hyperplasia, shrink tumor lesions, this case allows us consider whether in breast cancer new adjuvant chemotherapy combined Chinese medicine internal effect can be better, and provide new ideas for clinical treatment.
根据中医理论,手术创伤和化疗会加重患者气血亏虚,损伤经络。中医与新辅助化疗(NACT)联合应用不仅可以改善上述症状,还有望减轻乳腺癌化疗的不良反应,如恶心、呕吐,从而提高患者依从性,实现肿瘤缩小甚至无瘤状态,为乳腺癌的临床治疗提供新的诊疗思路。本文报道1例人表皮生长因子受体2(HER-2)阳性浸润性乳腺癌患者采用中药联合NACT治疗的病例。治疗2个月后病灶消失,并有效减轻了NACT期间的恶心及食欲不振症状。
患者为女性,54岁,无意中发现双侧乳房肿块伴刺痛1年余。在此期间,患者未予任何治疗,肿块逐渐增大,质地硬,边界不清。否认乳腺癌家族遗传史。经乳腺穿刺活检,患者被诊断为双侧浸润性导管癌(右腋窝及锁骨上淋巴结多发转移),T4N3M0(肿瘤分期依据),II期C,HER-2阳性。在NACT过程中,患者主诉严重恶心、呕吐,严重影响生活质量及化疗信心。
患者被诊断为双侧浸润性导管癌(右腋窝及锁骨上淋巴结多发转移),T4N3M0,II期C,HER-2阳性。
患者接受NACT治疗,并口服中药。
联合治疗2个月后,乳房肿块缩小,恶心、呕吐症状明显缓解,食欲好转。NACT结束时切除的乳腺组织活检显示上、下、内、外及基底均无病变。
中药内服效果显著且安全,新辅助化疗联合中药内服可有效改善恶心、呕吐症状,有效抑制肿瘤增生,缩小肿瘤病灶,本例促使我们思考在乳腺癌新辅助化疗中联合中药内服效果是否更佳,为临床治疗提供新思路。